"CD79 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Components of the B-cell antigen receptor that function in B-cell antigen receptor heavy chain transport to the PLASMA MEMBRANE. They are expressed almost exclusively by B-LYMPHOCYTES and are markers for B-cell NEOPLASMS.
| Descriptor ID |
D051925
|
| MeSH Number(s) |
D12.776.124.790.651.950.500 D12.776.377.715.548.950.500 D12.776.543.750.705.816.821.500
|
| Concept/Terms |
CD79 Antigens- CD79 Antigens
- Antigens, CD79
- CD79 Antigen
- Antigen, CD79
CD79b Antigens- CD79b Antigens
- Antigens, CD79b
- Igbeta Antigen
- Antigen, Igbeta
- CD79b Antigen
- Antigen, CD79b
- Immunoglobulin-Associated Beta Protein
- Immunoglobulin Associated Beta Protein
- B-Cell Antigen Receptor Complex Associated Protein Beta-Chain
- B Cell Antigen Receptor Complex Associated Protein Beta Chain
CD79a Antigens- CD79a Antigens
- CD79a Antigen
- Antigen, CD79a
- Immunoglobulin-Associated Alpha Protein
- Immunoglobulin Associated Alpha Protein
- IgM-Alpha Component
- IgM Alpha Component
- Antigens, CD79a
|
Below are MeSH descriptors whose meaning is more general than "CD79 Antigens".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Blood Proteins [D12.776.124]
- Serum Globulins [D12.776.124.790]
- Immunoglobulins [D12.776.124.790.651]
- Receptors, Antigen, B-Cell [D12.776.124.790.651.950]
- CD79 Antigens [D12.776.124.790.651.950.500]
- Globulins [D12.776.377]
- Serum Globulins [D12.776.377.715]
- Immunoglobulins [D12.776.377.715.548]
- Receptors, Antigen, B-Cell [D12.776.377.715.548.950]
- CD79 Antigens [D12.776.377.715.548.950.500]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Antigen [D12.776.543.750.705.816]
- Receptors, Antigen, B-Cell [D12.776.543.750.705.816.821]
- CD79 Antigens [D12.776.543.750.705.816.821.500]
Below are MeSH descriptors whose meaning is more specific than "CD79 Antigens".
This graph shows the total number of publications written about "CD79 Antigens" by people in this website by year, and whether "CD79 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD79 Antigens" by people in Profiles.
-
Igß ubiquitination activates PI3K signals required for endosomal sorting. J Exp Med. 2017 Dec 04; 214(12):3775-3790.
-
B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22). Am J Clin Pathol. 2013 Sep; 140(3):355-62.
-
Cloning of a hamster anti-mouse CD79B antibody sequences and identification of a new hamster immunoglobulin lambda constant IGLC gene region. Immunogenetics. 2013 Jun; 65(6):473-8.
-
Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol. 2004 Oct; 5(10):1069-77.
-
The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways. Mol Cell Biol. 2002 Apr; 22(8):2524-35.
-
Receptor-facilitated antigen presentation requires the recruitment of B cell linker protein to Igalpha. J Immunol. 2002 Mar 01; 168(5):2127-38.
-
Histological and immunohistochemical characterization of extranodal diffuse large-cell lymphomas with prominent spindle cell features. Histopathology. 2001 Nov; 39(5):476-81.
-
Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol. 2001 Nov; 14(11):1147-56.
-
CD79: a review. Appl Immunohistochem Mol Morphol. 2001 Jun; 9(2):97-106.
-
Igalpha: B all that you can B. J Clin Invest. 1999 Oct; 104(8):1011-2.